Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

Judicial Qualifications Commission of Georgia Hearing Panel issues sanction recommendation for Atlanta Judicial Circuit Judge. Panel recommends Supreme Court of Georgia remove Fulton County Superior ...

Is it true that certain nasal sprays can prevent covid? Scientists are researching at least two sprays that target the coronavirus where it most commonly enters our bodies — the nose. Both sprays are ...

Chronic rhinosinusitis (CRS) is a surprisingly common but under-recognized disease that affects nearly one billion people worldwide, or about 12% of the population. Defined as a long-lasting ...

LONDON, Sept 16 (Reuters) - An asylum seeker who arrived in Britain on a small boat cannot be removed to France pending a full legal challenge, London's High Court ruled on Tuesday, in an early ...

Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...

About The Study: Among patients with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, stapokibart, a novel monoclonal antibody, reduced polyp size and ...

EnQuest has completed the removal of topsides from its Heather Alpha platform in the UK North Sea, the London-listed operator said on Thursday. Allseas’ giant heavy lift vessel, the Pioneering Spirit, ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

CRSwNP often coexists with asthma, complicating treatment and reducing health-related quality of life. Standard therapies for CRSwNP, like nasal irrigation and corticosteroids, often inadequately ...